It is a hallucinogenic drug, and is a controlled substance designed for use as an aesthetics. It also has now been touted for ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

From the ancient Egyptians' use of electric fish to treat headaches to the invention of pacemakers to regulate heart rhythms ...

Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

EXISTING drugs already dished out on the NHS could slash dementia risk, a new study has revealed. While new drugs are ...

A new paper led by Professor Imanuel Lerman of UC San Diego provides a review of the field of bioelectronic medicine and the most promising opportunities for life-changing new therapies and ...

The accelerating sales growth of Johnson & Johnson's Spravato could go up yet another gear after the FDA approved a third ...

Now, a new crop of buzzy non-invasive VNS gadgets promises to relieve stress, sharpen focus and improve sleep in mere minutes ...

Unfortunately, we also found that GLP-1 drugs come with significant side effects and increase the risk of 19 health ...